Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

915

SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells

Sylvia Müller1, Yuan Chen, Torsten Ginter

  • 1Center for Molecular Biomedicine, University of Jena, Department of Biochemistry, Jena, Germany.

Oncotarget
|May 17, 2014
PubMed

Insights

Seven-in-absentia-2 (SIAH2) targets tyrosine kinase-2 (TYK2) for degradation, suppressing STAT3 signaling in lung cancer. Higher SIAH2 levels in squamous cell carcinoma suggest it as a novel marker for this lung cancer subtype.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Janus tyrosine kinases (JAKs) and tyrosine kinase-2 (TYK2) are hyperactivated in tumors, with JAK1/JAK2 signaling through STAT3 in lung cancers.
  • The role of TYK2 in lung cancer has not been previously established.
  • E3 ubiquitin ligase SIAH2's role in regulating TYK2 stability and lung cancer has not been reported.

Purpose of the Study:

  • To investigate the role of TYK2 in lung cancer.
  • To identify the regulatory mechanisms of TYK2 in lung cancer cells.
  • To explore the potential of SIAH2 as a molecular marker in non-small cell lung cancer (NSCLC) subtypes.

Main Methods:

  • Investigated TYK2-STAT3 signaling in lung cancer cells.
  • Assessed the effect of E3 ubiquitin ligase SIAH2 on TYK2 protein levels and STAT3 activation.
  • Analyzed SIAH2 and STAT3 phosphorylation levels in primary non-small cell lung cancer (NSCLC) patient samples (adenocarcinoma vs. squamous cell carcinoma).
  • Examined the impact of p53 activation on SIAH2, TYK2, STAT1, and STAT3.

Main Results:

  • Identified a novel TYK2-STAT3 signaling pathway in lung cancer cells.
  • Demonstrated that SIAH2 promotes proteasomal degradation of TYK2, suppressing STAT3 activation.
  • Found significantly higher SIAH2 levels and reduced STAT3 phosphorylation in lung squamous cell carcinoma (SCC) compared to lung adenocarcinoma (ADC).
  • Showed that p53 activation induces SIAH2, leading to TYK2 depletion and abrogated STAT1/STAT3 phosphorylation.

Conclusions:

  • SIAH2 is a novel regulator of TYK2 stability and STAT3 signaling in lung cancer.
  • SIAH2 serves as a potential molecular marker for distinguishing lung squamous cell carcinoma from lung adenocarcinoma.
  • The p53-SIAH2-TYK2 axis represents a distinct mechanism from SOCS-mediated inhibition and offers potential therapeutic targets in lung cancer.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.5K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K